TL;DR
The DEA telehealth rule applies to federally controlled substances prescribed through telemedicine. It does not govern every online prescription. Semaglutide and tirzepatide are not federally controlled substances, so other federal requirements, state law, clinician licensing, and pharmacy rules are usually more relevant to GLP-1 care. Because temporary telemedicine policies can change, we recommend checking the controlling federal notice before each new controlled-substance prescription.
DEA Telehealth Prescribing Rule: The Short Answer
Federal law generally requires a valid medical evaluation before a clinician prescribes a controlled substance. Temporary telemedicine policies may allow qualifying clinicians to prescribe certain controlled medications without first conducting an in-person examination.
Those policies do not create a right to receive medication. The clinician must have appropriate prescribing authority, act for a legitimate medical purpose, and comply with applicable federal and state requirements. A pharmacy also conducts its own review before dispensing.
Official sources: Check the controlling Federal Register notice and the DEA Diversion Control Division rather than relying on an old deadline in a news article.
Is there a DEA telehealth extension for 2026?
Do not assume that an earlier extension remains active. Temporary authorities can expire, be replaced, or receive another extension. We recommend confirming the effective dates in the controlling Federal Register notice on the date of the appointment or prescription.
A proposed rule is not binding merely because it has been announced. Likewise, a final rule may have a later effective date.
What the extension does not guarantee
A temporary extension does not:
- Override state law or licensing requirements.
- Require a clinician to prescribe.
- Require a pharmacy to dispense.
- Apply to every medicine ordered online.
- Eliminate the need for a valid medical evaluation.
Which Prescriptions the DEA Rule Covers
The DEA’s telemedicine requirements concern federally controlled substances. They do not control every prescription drug.
| Schedule | Common examples | General refill treatment |
|---|---|---|
| II | Amphetamine and methylphenidate products | A new prescription is required |
| III | Buprenorphine and certain codeine products | Refills may be authorized |
| IV | Alprazolam and similar sedatives | Refills may be authorized |
| V | Certain low-codeine products | Treatment depends on the product and applicable law |
A product’s active ingredient, strength, and formulation can affect its classification. Clinicians and pharmacies should verify the exact medication rather than relying on a brand or drug category.
Schedule II drugs
Many stimulant medications are classified as Schedule II controlled substances. They cannot be handled as ordinary refills; each prescription requires a current prescribing decision.
A telemedicine exception may affect whether an earlier in-person examination is necessary. It does not remove state requirements, clinical monitoring, or pharmacy review.
Schedule III, IV, and V drugs
Some prescriptions in these schedules may include refill authorization. Whether a refill can be dispensed still depends on the original prescription, the medication, applicable time limits, state law, and clinician approval.
We recommend distinguishing controlled status from clinical risk. A medication is controlled because of its legal classification, not simply because it requires careful monitoring.
Do DEA Telehealth Rules Apply to Semaglutide or Tirzepatide?
Semaglutide and tirzepatide are prescription medications, but they are not federally scheduled controlled substances. The DEA’s controlled-substance telemedicine framework is therefore not the main federal rule governing most prescriptions for these drugs.
Patients still need an appropriate evaluation, medical screening, state-compliant care, and a lawful dispensing source. We apply that distinction when discussing online care through Temi’s medication platform, without suggesting that every patient qualifies for treatment.
What still controls an online GLP-1 prescription
An online GLP-1 prescription can depend on:
- Clinician licensing and scope of practice.
- The patient’s location during the appointment.
- Health history, contraindication screening, and follow-up.
- State telehealth and pharmacy requirements.
- The prescribed product and dispensing source.
- Applicable FDA requirements.
Compounding requirements are separate from DEA scheduling. Patients can also review location-specific resources, including our guide to GLP-1 weight-loss care in Michigan.
Why “prescription drug” does not mean “controlled substance”
A prescription drug requires authorization from a licensed prescriber. A controlled substance is also assigned to a federal schedule under the Controlled Substances Act.
Some medications fit both definitions, while many fit only the first. The exact ingredient and formulation determine which rules apply.
When an In-Person Visit Is Required
The Ryan Haight Act establishes an in-person evaluation framework for many internet prescriptions involving controlled substances, subject to recognized exceptions. A valid telemedicine policy may modify that requirement temporarily or for a defined category of care.
Even when federal policy permits remote prescribing, a clinician may require an office visit because of state law, medical history, the requested medication, or clinical judgment.
Temporary flexibility versus a permanent rule
Temporary extensions and permanent regulations are not interchangeable. Before relying on either, check:
- Whether the policy is final.
- When it becomes effective.
- Which medications and visit formats it covers.
- Whether a later notice changed its implementation.
We focus on the rule effective when care is provided, not simply the date on which an agency announced or published it.
What counts as a valid medical evaluation
A video call does not automatically make a prescription valid. The clinician must gather enough information to support safe treatment and a lawful prescribing decision.
The necessary evaluation varies with the medication, diagnosis, medical history, visit format, and governing law.
Video, Audio-Only, and Buprenorphine Rules
Federal and state rules may treat two-way video differently from audio-only care. Audio-only authority should not be assumed to cover every controlled substance or treatment situation.
Buprenorphine prescribed for opioid use disorder also has a distinct federal rulemaking history. Clinicians should verify which temporary and permanent provisions are currently effective.
When video may be required
Video may be required by federal authority, state law, or the clinician’s policy. The answer depends on the medication and purpose of treatment.
We recommend confirming the appointment format beforehand. Booking an audio-only visit does not establish eligibility for a prescription.
The separate buprenorphine pathway
Buprenorphine requirements may address visit format, prescription-monitoring checks, identity verification, pharmacy documentation, and follow-up care.
Because implementation dates can change, practices should consult the controlling text rather than apply an announced policy before it takes effect.
Refills, New Prescriptions, Transfers, and Changes of Clinician
A refill uses authorization attached to an existing prescription. A new prescription is a new order. A transfer moves eligible prescription information between pharmacies.
Before medication runs out:
- Confirm the exact drug, strength, and formulation.
- Ask whether the next order is a refill or new prescription.
- Check whether another appointment is required.
- Confirm that the clinician can prescribe where the patient is located.
- Ask whether the pharmacy can process the order.
Our prescription transfer checklist explains practical steps that may reduce delays.
If the same clinician handles the next prescription
Check for remaining refill authorization and required follow-up. The pharmacy may still need to verify the prescription, review its records, or order stock.
If a new clinician handles the next prescription
A new clinician must make an independent clinical and legal decision. Prior records may help, but they do not guarantee continuation of treatment.
The clinician also needs appropriate authority for the state where the patient is physically located during the appointment.
Federal Permission Is Only the First Check
We use four checks when reviewing telehealth prescribing:
- Federal DEA authority.
- State law.
- Clinician licensing and registration.
- Pharmacy policy.
Insurance determines coverage and may require prior authorization. It does not determine whether federal law permits a prescription. Paying cash does not remove prescribing requirements.
State law and cross-state care
The patient’s physical location during an appointment generally matters for clinician licensing. State law may also impose consent, examination, monitoring, or documentation requirements.
Pharmacy and health-plan limits
A legally issued prescription does not compel a pharmacy to dispense it. Pharmacists may consider verification duties, state law, stock, and company policy.
Our pharmacy guides can help patients understand common fulfillment processes, although each pharmacy makes its own decision.
DEA Registration, Lookup, Renewal, and the 5% Rule
DEA registration belongs to the prescriber or other registrant, not the patient. The DEA Diversion Control Division provides official resources for new applications, renewals, registration changes, status checks, and certificate requests.
Search results for “DEA” may include unrelated programs, such as Department of Veterans Affairs education benefits. We recommend starting with the official DEA website.
What is the DEA 5% rule?
The 5% rule concerns limited distribution of controlled substances between qualifying registrants. It is not a patient refill cap, dosage limit, or telehealth prescribing quota.
Because its application depends on a registrant’s activities and the governing regulation, clinicians should confirm compliance through current DEA guidance rather than apply the term to ordinary patient prescriptions.
How to verify a prescriber’s authority
Patients can ask a clinician or practice about its licensing and prescribing process. The dispensing pharmacy performs its own required checks.
Clinicians should use official DEA registration, account-access, and renewal tools. Third-party directories should not be treated as conclusive proof of federal prescribing authority.
Patient Questions and Action Checklist
Use this sequence before the next prescription:
- Identify the exact medication.
- Determine whether it is federally controlled.
- Distinguish a refill, new prescription, and transfer.
- Confirm the required visit format and state rules.
- Contact the dispensing pharmacy.
Do not change a dose, share medication, or buy prescription products from an unverified source.
Is there a DEA telehealth extension for 2026?
Check the controlling Federal Register notice. Temporary prescribing authority can change, and an old article may not reflect the rule currently in effect.
What is the DEA 5% rule?
It addresses certain distributions between DEA registrants. It is not a general limit on patient prescriptions, refills, or telehealth care.
Is there a 28-day prescription rule for controlled substances in Ohio?
There is no universal DEA rule making every Ohio controlled-substance prescription a 28-day prescription. Requirements may vary by medication, schedule, indication, prescription type, and current Ohio law.
Can my doctor refill my medicine online?
Possibly. The answer depends on the drug, existing refill authorization, clinician relationship, patient location, visit format, and pharmacy policy. DEA controlled-substance rules are generally not the deciding factor for semaglutide or tirzepatide.
FAQ
What DEA rules apply to telehealth prescriptions?
The applicable framework may include the Ryan Haight Act, current telemedicine exceptions, federal scheduling and refill requirements, and medication-specific regulations. State law and pharmacy policy remain separate checks.
Can Schedule II medicine be refilled through telehealth?
Schedule II prescriptions are not refilled. A clinician may issue a new prescription after an appropriate evaluation if current federal and state requirements permit it.
Does switching telehealth companies preserve my prescription?
No. The new clinician must conduct an independent evaluation and have authority to prescribe where the patient is located. Previous records can inform that decision but do not determine it.
Can a pharmacy decline a valid telehealth prescription?
Yes. A pharmacy may review applicable law, prescriber information, prescription records, stock, and internal policy before deciding whether to dispense.
Check Your Next Prescription
Use Temi to organize medication details and prepare questions for the clinician and pharmacy before the next prescription is due. Get started with Temi’s medication platform.
